The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries.

Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at ...

The drug is called Journavx and doctors believe it has no potential for addiction and dependence.

Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...

The Food and Drug Administration has approved a first of its kind prescription pain medication that is non-opioid.

A new non-opioid painkiller, JournaVX, has received approval from the FDA, marking the first new type of pain medication in ...

The FDA just approved a new pain medication called Journavx, which promises to treat pain without the risk of developing an addiction. 21 News is joined by Dr. Jianguo Cheng with the Cleveland Clinic ...

A new drug approved Thursday by the FDA offers pain management but is not addictive. Unlike opioids, it treats pain signals ...

An effort two decades in the making, Vertex Pharmaceuticals Inc.’s suzetrigine gained U.S. FDA approval as the first drug targeting the NaV1.8 pain signal. Branded Journavx, the oral small molecule is ...

The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.

The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.

Journavx (suzetrigine) is said to reduce pin by "targeting a pain-signaling pathway involving sodium channels in the ...